Cargando…
The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
There is no definite cure for Alzheimer’s disease (AD) due to its multifactorial origin. Drugs that inhibit acetylcholinesterase (AChE), such as rivastigmine, are promising symptomatic treatments for AD. Emerging evidence suggests that insulin therapy can hinder several aspects of AD pathology. Insu...
Autores principales: | Jamshidnejad-Tosaramandani, Tahereh, Kashanian, Soheila, Babaei, Mahsa, Al-Sabri, Mohamed H., Schiöth, Helgi B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617642/ https://www.ncbi.nlm.nih.gov/pubmed/34832918 http://dx.doi.org/10.3390/ph14111136 |
Ejemplares similares
-
Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media
por: Jamshidnejad-Tosaramandani, Tahereh, et al.
Publicado: (2023) -
Statins and cognition: Modifying factors and possible underlying mechanisms
por: Jamshidnejad-Tosaramandani, Tahereh, et al.
Publicado: (2022) -
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
por: Shamsi, Anas, et al.
Publicado: (2020) -
Improvement of cytotoxicity and necrosis activity of ganoderic acid a through the development of PMBN-A.Her2-GA as a targeted nano system
por: Motamed Fath, P., et al.
Publicado: (2022) -
Silanetriols as in vitro inhibitors for AChE
por: Blunder, Martina, et al.
Publicado: (2011)